版权说明 操作指南
首页 > 成果 > 详情

Bioequivalence Study of Two Empagliflozin Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions

认领
导出
Link by DOI
反馈
分享
QQ微信 微博
成果类型:
期刊论文
作者:
Lei, Yuyan;Liu, Yuan;Gao, Lichen;Peng, Xueqiong;Chen, Lulu;...
通讯作者:
Li, XH
作者机构:
[Lei, Yuyan] Second Nanning People's Hosp, Phase Clin Study Lab 1, Nanning, Peoples R China.
[Lei, Yuyan; Li, Xiaohui; Li, XH] Cent South Univ, Xiangya Sch Pharmaceut Sci, Dept Pharmacol, 172 Tongzipo Rd, Changsha 410000, Hunan, Peoples R China.
[Liu, Yuan; Xu, Junmei] Cent South Univ, Xiangya Hosp 2, Dept Anesthesiol, Changsha, Peoples R China.
[Gao, Lichen] Univ South China, Changsha Cent Hosp, PhaseIClin Study Ctr, Dept Pharm,Canc Inst, Changsha, Peoples R China.
[Peng, Xueqiong] Univ South China, Inst Pharm & Pharmacol, Hengyang, Peoples R China.
通讯机构:
[Li, XH ] C
Cent South Univ, Xiangya Sch Pharmaceut Sci, Dept Pharmacol, 172 Tongzipo Rd, Changsha 410000, Hunan, Peoples R China.
语种:
英文
关键词:
bioequivalence;empagliflozin;healthy subject;LC-MS/MS;pharmacokinetics
期刊:
Clinical Pharmacology in Drug Development
ISSN:
2160-763X
年:
2025
基金类别:
International Scientific and Technological Innovation Cooperation Base for Bioanalysis of Complex Matrix Samples
机构署名:
本校为其他机构
院系归属:
药学与生物科学学院
摘要:
Empagliflozin is a highly selective sodium-glucose cotransporter 2 inhibitor and an effective medication for treating diabetes. This study aimed to assess the pharmacokinetics and bioequivalence of two 10-mg empagliflozin tablets in healthy Chinese subjects and examine food's effect on absorption. The research was conducted as a single-center, randomized, open-label, single-dose, 2-way crossover study involving 47 subjects (fasting: n = 23, fed: n = 24). Subjects received either the test or reference drug and switched to the alternative after a 7-day washout period. Blood samples were collecte...

反馈

验证码:
看不清楚,换一个
确定
取消

成果认领

标题:
用户 作者 通讯作者
请选择
请选择
确定
取消

提示

该栏目需要登录且有访问权限才可以访问

如果您有访问权限,请直接 登录访问

如果您没有访问权限,请联系管理员申请开通

管理员联系邮箱:yun@hnwdkj.com